Reuters logo
8 months ago
BRIEF-GSK's Viiv announces positive results from initial HIV phase III studies
December 20, 2016 / 7:10 AM / 8 months ago

BRIEF-GSK's Viiv announces positive results from initial HIV phase III studies

Dec 20 (Reuters) - Glaxosmithkline Plc

* First phase iii studies to show efficacy of two-drug regimen as maintenance therapy

* Viiv healthcare announces positive results from first phase iii studies of two-drug hiv treatment regimen Source text for Eikon: Further company coverage: (Reporting By UK Bureau)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below